Cigna Group $CI Position Raised by MUFG Securities EMEA plc

MUFG Securities EMEA plc increased its position in shares of Cigna Group (NYSE:CI) by 721.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,955 shares of the health services provider’s stock after purchasing an additional 36,846 shares during the period. MUFG Securities EMEA plc’s holdings in Cigna Group were worth $11,547,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Cary Street Partners Investment Advisory LLC grew its position in Cigna Group by 11.0% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock worth $100,000 after buying an additional 36 shares during the last quarter. OLD National Bancorp IN grew its position in Cigna Group by 3.7% in the fourth quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock worth $284,000 after buying an additional 37 shares during the last quarter. CYBER HORNET ETFs LLC grew its position in Cigna Group by 5.3% in the fourth quarter. CYBER HORNET ETFs LLC now owns 801 shares of the health services provider’s stock worth $220,000 after buying an additional 40 shares during the last quarter. Physician Wealth Advisors Inc. grew its position in Cigna Group by 1.5% in the third quarter. Physician Wealth Advisors Inc. now owns 2,712 shares of the health services provider’s stock worth $782,000 after buying an additional 41 shares during the last quarter. Finally, Cookson Peirce & Co. Inc. grew its position in Cigna Group by 0.8% in the third quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock worth $1,428,000 after buying an additional 41 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Down 0.1%

Cigna Group stock opened at $277.08 on Monday. The company’s fifty day simple moving average is $278.32 and its 200-day simple moving average is $277.01. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 12 month low of $239.51 and a 12 month high of $338.89. The stock has a market cap of $73.30 billion, a P/E ratio of 11.75, a P/E/G ratio of 1.00 and a beta of 0.28.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. During the same period in the previous year, the company posted $6.74 EPS. Cigna Group’s revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, sell-side analysts forecast that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Thursday, June 4th. Cigna Group’s payout ratio is currently 26.45%.

Insider Activity at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. The trade was a 85.46% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts have issued reports on CI shares. Leerink Partners lifted their price target on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research report on Friday, February 6th. Sanford C. Bernstein lifted their price target on shares of Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 5th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Barclays lowered shares of Cigna Group from an “overweight” rating to an “equal weight” rating and decreased their price target for the stock from $310.00 to $304.00 in a research report on Tuesday, May 26th. Finally, Jefferies Financial Group decreased their price target on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research report on Monday, April 20th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and a consensus target price of $339.50.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.